Tag: Eduardo Bravo

Nordic Nanovector initiates Betalutin rituximab combo trial in 2L FL

pharmanewsdaily- November 4, 2018

Nordic Nanovector has announced the dosing of the first patient in a phase 1b clinical trial called Archer-1 for evaluating the combination of its investigational ... Read More